Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why The company expects to soon expand from a single-product player to a "multi-product innovator."
EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.
EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating A Relative Strength Rating upgrade for AbbVie shows improving technical performance.
EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023 EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level.
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Panbela Therapeutics, Inc. (
NASDAQ: PBLA ) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (
NASDAQ: SOFI ) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.
Earnings Scheduled For March 7, 2024 Companies Reporting Before The Bell • CI&T (
NYSE:CINT ) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
